, ? tableau 1 : Liste des champignons comestbles et médicinaux pouvant être cultvés (source : FAO.org) ? tableau 2 : Producton mondiale de champignons (source : FAO.org)

, ? tableau 3 : Actons thérapeutques des oligoéléments composant les champignons (source : Poirier Antunes J., 2019) d'après, vol.20, p.32

, Classifcaton taxonomique des champignons étudiés (source : Poirier Antunes J., 2019) d'après mycobank.org, vol.4

, ? tableau 5 : Bilan des actvités thérapeutques d'Agaricus subrufescens (source : Poirier Antunes J., 2019) d'après, vol.71, pp.73-77

, ? tableau 6 : Bilan des actvités thérapeutques de Ganoderma lucidum, pp.83-89

, ? tableau 7 : Bilan des actvités thérapeutques de Grifola frondosa, pp.92-98

, ? tableau 8 : Bilan des actvités thérapeutques d'Hericium erinaceus (source : Poirier Antunes J., 2019) d'après, pp.102-105

, Bilan des actvités thérapeutques de Lentinula edodes, vol.45, p.114

, ? tableau 10 : Bilan des actvités thérapeutques de Monascus purpureus, vol.119, pp.121-125

, ? tableau 11 : Bilan des actvités thérapeutques d'Ophiocordyceps sinensis (source : Poirier Antunes J., 2019) d'après, vol.82, pp.146-152

, ? tableau 12 : Bilan des actvités thérapeutques de Pleurotus ostreatus, pp.154-158

, Compositon de Saccharomyces cerevisiae en vitamines du groupe B (réalisaton personnelle de, Poirier Antunes J, vol.13, 2019.

, ? tableau 14 : Bilan des actvités thérapeutques de Saccharomyces cerevisiae (source : Poirier Antunes J., 2019) d'après, pp.174-176

, ? tableau 15 : Bilan des actvités thérapeutques de Trametes versicolor, vol.100, pp.178-182

, Classifcaton des champignons thérapeutques en foncton de leur(s) tropisme(s) d'acton (d'après des études cliniques réalisées chez l'homme) (source : Poirier Antunes J., 2019) d'après, ? tableau, vol.16, pp.71-182

, Schéma d'interprétation des diférents stade de la reproduction sexuée chez le Basidiomycète (source : d'après suprago, vol.6

, Mycothérapie: définition et explications

. Aquaportail,

D. Sur,

M. Lapico, Healing fungi : The way of wellness

A. Tardif, La mycothérapie ou Les propriétés médicinales des champignons

C. Francia, F. Fons, P. Poucheret, and S. Rapior, Actvités biologiques des champignons : Utlisatons en médecine traditonnelle. Ann Société D'Horticulture D, Histoire Nat L'Hérault. 1 janv, vol.147, pp.77-88, 2007.

R. G. Wasson and R. Heim, Les champignons hallucinogènes du Mexique

D. Garon and C. Gueguen, Biodiversité et évolution du monde fongique, EDP Sciences, vol.220, 2009.

. Uclouvain, Morphologie et Physiologie des Mycètes, 2016.

D. Sur,

J. C. Seconde, Les champignons de santé et de longévité. Grancher, vol.303, 2014.

M. Francis, Tous les champignons ont-ils un chapeau? UAE GIE, vol.182, 2014.

P. G. Cnpf, Le champignon, allié de l'arbre et de la forêt, 2015.

. Smhv and . Société, Mycologique des Hautes-Vosges

D. Sur,

P. Chifoleau, Les champignons de la famille des Agaricacées sources d'innovations thérapeutiques ?

W. F. Wang, Z. Xu, and Z. Ding, Bioactve Mushroom Polysaccharides: A Review on Monosaccharide Compositon, Disponible sur, vol.22, pp.13-2017

C. Castan, La levure de bière: un champignon aux multiples bienfaits pour la santé et la beauté, 2016.

M. Knop, Yeast cell morphology and sexual reproducton--a short overview and some consideratons, C R Biol. sept, vol.334, issue.8-9, pp.599-606, 2011.

I. Ferreira-fennessy, Saccharomyces cerevisiae : importance dans le développement des sociétés humaines. Rôle dans l'industrie agro-alimentaire et en thérapeutique, 1997.

F. Houis, Les champignons de la famille des Tricholomatacées : sources d'innovations thérapeutiques ?, 2011.

S. Boisson, Contribution à une approche ethnomycologique du Shiitake (Lentinula edodes (Berk.) Pegler), 2014.

B. Buyck and J. Polese, Le traité rustica des champignons, Rustca, vol.383, 2004.

M. Rampin, Champignons « médicinaux » : de l'usage traditionnel aux compléments alimentaires, 2017.

B. Guiot, Les intérêts pharmacologiques du polypore « Laricifomes ofcinalis, 2016.

U. Peintner and R. Pöder, Ethnomycological remarks on the Iceman's fungi. In: Bortenschlager S, Oeggl K, éditeurs. The Iceman and his Natural Environment: Palaeobotanical Results, The Man in the Ice). Disponible sur, pp.143-50, 2000.

U. Grienke, M. Zöll, U. Peintner, and J. M. Rollinger, European medicinal polypores -a modern view on traditonal uses, J Ethnopharmacol. 3 juill, vol.154, issue.3, pp.564-83, 2014.

P. U. Unschuld, Médecines chinoises. Indigène, vol.131, 2001.

R. Ngo, S. Rapior, G. Ninot, F. Fons, and N. Calcet, La mycothérapie, inspirée des savoirs ancestraux asiatiques, dans la pratique ofcinale française, 2011.

D. Hoizey, Histoire de la médecine chinoise

E. Marié, Précis de médecine chinoise. Dangles, Médicale et Paramédicale), 2002.

H. Ottino, Dictionnaire de Médecine chinoise. Larousse, vol.334, 2001.

I. Jakopovich, New dietary supplements from medicinal mushrooms: Dr Myko San--a registraton report, Int J Med Mushrooms, vol.13, issue.3, pp.307-320, 2011.

N. Santana, M. , M. C. Oliveira, G. Hanai-yoshida, V. Oshima-franco et al., Naturally Occurring Ingredients as Potential Antiaging Cosmetics, vol.30, 2011.

D. Bruchon, Dictionnaire Harry Potter (Anglais-Francais). Temps, vol.160, 2007.

D. Bederska-?ojewska, S. Swiatkiewicz, and B. Muszynska, The use of Basidiomycota mushrooms in poultry nutriton-A review, Anim Feed Sci Technol. 1 juin, vol.230, 2017.

. Vidal and . Fingolimod,

D. Sur,

A. Cassar, La culture des macromycètes entrant dans la composition des compléments alimentaires, 2016.

P. Stamets, Growing gourmet and medicinal mushrooms. 3 e éd, vol.574, 2000.

, Champignons comestibles sauvages : Vue d'ensemble sur leurs utilisations et leur importance pour les populations, FAO (Food Agriculture Organizaton of the United Natons), Iqbal M

. Rome, Trade restrictons afectng internatonal trade in non-wood forest products), vol.170, 1995.

C. Sánchez, Cultvaton of Pleurotus ostreatus and other edible mushrooms, Appl Microbiol Biotechnol. févr, vol.85, issue.5, pp.1321-1358, 2010.

B. Donatni, Introducton à la mycothérapie: généralités sur l'intérêt des principaux mycelia, Phytothérapie. 1 juin, vol.8, pp.191-198, 2010.

D. Silva, D. Rapior, S. Fons, F. Bahkali, A. Hyde et al., Medicinal mushrooms in supportve cancer therapies: an approach to ant-cancer efects and putatve mechanisms of acton, Curr Pharm Des, vol.55, issue.1, pp.1-35, 2012.

F. Lamiaux, Artcle interview : Les champignons thérapeutiques du Dr Bruno Donatini [Internet]. uantqueMedia

L. Genevey and C. Schutz, Législation du complément alimentaire et étude des compositions de deux types de compléments alimentaires, 2009.

, Anses -Agence natonale de sécurité sanitaire de l'alimentaton, de l'environnement et du travail. Étude individuelle nationale des consommations alimentaires g (INCA g), 2017.

D. Sur,

S. Rapior, F. Fons, and S. , Principaux champignons utilisés dans les compléments alimentaires : utilisations et précautions d'emploi, 2015.

. Vidal and . Shiitaké,

. Eurekasanté,

D. Sur,

X. Yin, J. Ying, L. Li, H. Zhang, and H. Wang, A meta-analysis of lentnan injecton combined with chemotherapy in the treatment of nonsmall cell lung cancer, Indian J Cancer, vol.52, issue.1, pp.29-31, 2015.

. Afssa, Avis relatif à la demande d'évaluation d'un propet d'arrêté relatif à l'emploi de substances à but nutritionnel ou physiologique et de plantes et préparations de plantes dans la fabrication de compléments alimentaires, Saisine, 2007.

D. Sur,

. Intracto,

. Centre-antpoisons-belge,

D. Sur,

. Dgccrf, Communiqué de presse relatif à la mise en garde de la consommation de Shiitaké à l'état cru, 2015.

, Anses -Agence natonale de sécurité sanitaire de l'alimentaton, de l'environnement et du travail. Saisine n°2011-SA-0120. Avis relatif à un propet d'arrêté sur l'emploi de plantes autres que les champignons dans les compléments alimentaires, 2012.

L. Gouill and E. , Les macromycètes : une possibilité thérapeutique contre le cancer?

. L'apoptose,

D. Sur,

, Cellule -Les fonctions cellulaire : l'apoptose

. Sagascience,

M. Simon, Les réponses immunitaires

. Cours-pharmacie,

D. Sur,

C. Braibant, Les champignons médicinaux. Edilivre, vol.136, 2013.

R. Talat, W. L. Baker, M. S. Pabilonia, C. M. White, and C. I. Coleman, The Efects of Barley-Derived Soluble Fiber on Serum Lipids, Ann Fam Med. mars, vol.7, issue.2, pp.157-63, 2009.

U. Tiwari and E. Cummins, Meta-analysis of the efect of ?-glucan intake on blood cholesterol and glucose levels. Nutr Burbank Los Angel Cty Calif, vol.27, pp.1008-1024, 2011.

S. S. Abumweis, S. Jew, and N. P. Ames, ?-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials, Eur J Clin Nutr. déc, vol.64, issue.12, pp.1472-80, 2010.

F. Andrade, E. Vieira-lobato, R. , V. Araújo, T. et al., Efect of beta-glucans in the control of blood glucose levels of diabetc patents: a systematc review, Nutr Hosp. 1 janv, vol.31, issue.1, pp.170-177, 2014.

A. Whitehead, E. J. Beck, S. Tosh, and T. Wolever, Cholesterol-lowering efects of oat ?-glucan: a metaanalysis of randomized controlled trials, Am J Clin Nutr. déc, vol.100, issue.6, pp.1413-1434, 2014.

C. Evans, D. C. Greenwood, D. E. Threapleton, C. L. Cleghorn, C. Nykjaer et al., Efects of dietary fbre type on blood pressure: a systematc review and meta-analysis of randomized controlled trials of healthy individuals, J Hypertens. mai, vol.33, issue.5, pp.897-911, 2015.

Y. Zou, D. Liao, H. Huang, T. Li, and H. Chi, A systematc review and meta-analysis of beta-glucan consumpton on glycemic control in hypercholesterolemic individuals, Int J Food Sci Nutr, vol.66, issue.4, pp.355-62, 2015.

X. Zhu, X. Sun, M. Wang, C. Zhang, Y. Cao et al., uanttatve assessment of the efects of betaglucan consumpton on serum lipid profle and glucose level in hypercholesterolemic subjects, Nutr Metab Cardiovasc Dis NMCD. août, vol.25, issue.8, pp.714-737, 2015.

H. Ho, J. L. Sievenpiper, A. Zurbau, S. Blanco-mejia, E. Jovanovski et al., A systematc review and meta-analysis of randomized controlled trials of the efect of barley ?-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reductoni-iv, Eur J Clin Nutr, vol.70, issue.11, pp.1239-1284, 2016.

H. Ho, J. L. Sievenpiper, A. Zurbau, S. Blanco-mejia, E. Jovanovski et al., The efect of oat ?glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reducton: a systematc review and meta-analysis of randomised-controlled trials, Br J Nutr, vol.116, issue.8, pp.1369-82, 2016.

L. He, J. Zhao, Y. Huang, and Y. Li, The diference between oats and beta-glucan extract intake in the management of HbA1c, fastng glucose and insulin sensitvity: a meta-analysis of randomized controlled trials, Food Funct. mars, vol.7, issue.3, pp.1413-1441, 2016.

X. L. Shen, T. Zhao, Y. Zhou, X. Shi, Y. Zou et al., Efect of Oat ?-Glucan Intake on Glycaemic Control and Insulin Sensitvity of Diabetc Patents: A Meta-Analysis of Randomized Controlled Trials, Nutrients. 13 janv, vol.8, issue.1, 2016.

L. Y. Hou, L. Li, G. Cheng, X. Sun, and S. Li, The Metabolic Efects of Oats Intake in Patents with Type 2 Diabetes: A Systematc Review and Meta-Analysis, Nutrients. 10 déc, vol.7, issue.12, pp.10369-87, 2015.

B. Donatni, Le Grifola frondosa (maïtaké) : un régulateur du syndrome métabolique: poids, cholestérol, glycémie et hypertension artérielle; accessoirement un immunostmulant, SpringerLink, vol.9, issue.6, pp.376-385, 2011.

E. Blandeau, Etat des lieux du potentiel anticancéreux de neuf champignons macroscopiques, 2012.

, Anses -Agence natonale de sécurité sanitaire de l'alimentaton, de l'environnement et du travail. Cueillir et consommer les champignons en toute sécurité, 2018.

C. Lima, A. Cordova-co-de, T. Nóbrega-o-de, S. S. Fungheto, and O. Karnikowski-mg-de, Does the Agaricus blazei Murill mushroom have propertes that afect the immune system? An integratve review, J Med Food. févr, vol.14, issue.1-2, pp.2-8, 2011.

D. Silva-de-souza, A. C. Correa, V. G. Goncalves-g-de, A. Soares, A. A. Bracht et al., Agaricus blazei Bioactve Compounds and their Efects on Human Health: Benefts and Controversies, Curr Pharm Des, vol.23, issue.19, pp.2807-2841, 2017.

S. P. Therkelsen, G. Hetland, T. Lyberg, I. Lygren, and J. E. , Cytokine Levels Afer Consumpton of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan TM , in Patents with Crohn's Disease and Ulceratve Colits in a Randomized Single-Blinded Placebo-Controlled Study, Scand J Immunol. déc, vol.84, issue.6, pp.323-354, 2016.

S. P. Therkelsen, G. Hetland, T. Lyberg, I. Lygren, and J. E. , Efect of the Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSanTM, on Symptoms, Fatgue and uality of Life in Patents with Crohn's Disease in a Randomized Single-Blinded Placebo Controlled Study, PloS One, vol.11, issue.7, p.159288, 2016.

C. Hsu, Y. Liao, S. Lin, K. Hwang, and P. Chou, The mushroom Agaricus Blazei Murill in combinaton with metormin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, doubleblinded, and placebo-controlled clinical trial, J Altern Complement Med N Y N. févr, vol.13, issue.1, pp.97-102, 2007.

C. Lima, V. C. Souza, M. C. Morita, M. D. Chiarello, and O. Karnikowski-mg-de, Agaricus blazei Murrill and infammatory mediators in elderly women: a randomized clinical trial, Scand J Immunol. mars, vol.75, issue.3, pp.336-377, 2012.

J. Tangen, A. Tierens, J. Caers, M. Binsfeld, O. K. Olstad et al., Immunomodulatory efects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patents with multple myeloma undergoing high dose chemotherapy and autologous stem cell transplantaton: a randomized, double blinded clinical study, BioMed Res Int, vol.201, issue.5, p.718539, 2015.

T. Stjve, Agaricus blazei murrill, un nouveau champignon gourmet et médicament qui nous vient du Brésil

. Observatoire-mycologique,

M. Greger and G. Stone, Comment ne pas mourir. Belfond, vol.576

P. H. Givelet, Disponible sur: htp://pharmacie.univ-lille.fr/index.php?id=460&type=0&jumpurl=fleadmin %2Fusertupload%2Fressourcestcommunes%2Ftheses%2FThesestExercice %2Fthesest2011%2Fpaget3%2FGIVELETtPierretHenri, 2011.

I. K. Cheah and B. Halliwell, Ergothioneine; antoxidant potental, physiological functon and role in disease, Biochim Biophys Acta. mai, vol.1822, issue.5, pp.784-93, 2012.

N. L. Klupp, D. Chang, F. Hawke, H. Kiat, H. Cao et al., Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors, Cochrane Database Syst Rev. 17 févr, issue.2, p.7259, 2015.

X. Jin, R. Beguerie, J. Sze, D. Chan, and G. , Ganoderma lucidum (Reishi mushroom) for cancer treatment, Cochrane Database Syst Rev. 13 juin, issue.6, p.7731, 2012.

J. Yuen and M. Gohel, Antcancer efects of Ganoderma lucidum: a review of scientfc evidence, Nutr Cancer, vol.53, issue.1, pp.11-18, 2005.

S. Legget, B. Koczwara, and M. Miller, The impact of complementary and alternatve medicines on cancer symptoms, treatment side efects, quality of life, and survival in women with breast cancer--a systematc review, Nutr Cancer, vol.67, issue.3, pp.373-91, 2015.

G. Wu, J. Guo, J. Bao, X. Li, X. Chen et al., Ant-cancer propertes of triterpenoids isolated from Ganoderma lucidum -a review, Expert Opin Investig Drugs. août, vol.22, issue.8, pp.981-92, 2013.

P. Rossi, R. Difrancia, V. Uagliariello, E. Savino, P. Tralongo et al., B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integratve medicine, Oncotarget. 15 mai, vol.9, issue.37, pp.24837-56, 2018.

Y. Gao, W. Tang, X. Dai, H. Gao, G. Chen et al., Efects of water-soluble Ganoderma lucidum polysaccharides on the immune functons of patents with advanced lung cancer, J Med Food, vol.8, issue.2, pp.159-68, 2005.

Y. Gao, S. Zhou, W. Jiang, M. Huang, and X. Dai, Efects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functons in advanced-stage cancer patents, Immunol Invest. août, vol.32, issue.3, pp.201-216, 2003.

V. Popovi?, J. ?ivkovi?, S. Davidovi?, M. Stevanovi?, and D. Stojkovi?, Mycotherapy of cancer: an update on cytotoxic and anttumor actvites of mushrooms, bioactve principles and molecular mechanisms of their acton, Curr Top Med Chem, vol.13, issue.21, pp.2791-806, 2013.

Y. Adachi, M. Okazaki, N. Ohno, and T. Yadomae, Enhancement of cytokine producton by macrophages stmulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa, Biol Pharm Bull. déc, vol.17, issue.12, pp.1554-60, 1994.

G. Deng, H. Lin, A. Seidman, M. Fornier, D. 'andrea et al., A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patents: immunological efects, J Cancer Res Clin Oncol. sept, vol.135, issue.9, pp.1215-1236, 2009.

N. Kodama, K. Komuta, and H. Nanba, Efect of Maitake (Grifola frondosa) D-Fracton on the actvaton of NK cells in cancer patents, J Med Food, vol.6, issue.4, pp.371-378, 2003.

P. Pyo, B. Louie, S. Rajamahanty, M. Choudhury, and S. Konno, Possible immunotherapeutc potentaton with D-Fracton in prostate cancer cells, J Hematol OncolJ Hematol Oncol. 4 déc, vol.1, p.25, 2008.

B. Louie, S. Rajamahanty, J. Won, M. Choudhury, and S. Konno, Synergistc potentaton of interferon actvity with maitake mushroom d-fracton on bladder cancer cells, BJU Int. avr, vol.105, issue.7, pp.1011-1016, 2010.

M. Degen, B. Alexander, M. Choudhury, M. Eshghi, and S. Konno, Alternatve Therapeutc Approach to Renal-Cell Carcinoma: Inducton of Apoptosis with Combinaton of Vitamin K3 and D-fracton, J Endourol. 1 déc, vol.27, issue.12, pp.1499-503, 2013.

M. Mayell, Maitake extracts and their therapeutc potental, Altern Med Rev J Clin Ther. févr, vol.6, issue.1, pp.48-60, 2001.

J. Chen, K. Tominaga, Y. Sato, H. Anzai, and R. Matsuoka, Maitake mushroom (Grifola frondosa) extract induces ovulaton in patents with polycystc ovary syndrome: a possible monotherapy and a combinaton therapy afer failure with frst-line clomiphene citrate, J Altern Complement Med N Y N. déc, vol.16, issue.12, pp.1295-1304, 2010.

K. W. Tsang, C. L. Lam, C. Yan, J. C. Mak, G. C. Ooi et al., Coriolus versicolor polysaccharide peptde slows progression of advanced non-small cell lung cancer, Respir Med. juin, vol.97, issue.6, pp.618-642, 2003.

C. K. Wong, P. S. Tse, E. Wong, P. C. Leung, K. P. Fung et al., Immunomodulatory efects of yun zhi and danshen capsules in health subjects--a randomized, double-blind, placebo-controlled, crossover study, Int Immunopharmacol. févr, vol.4, issue.2, pp.201-212, 2004.

H. Kawagishi, A. Shimada, R. Shirai, K. Okamoto, F. Ojima et al., Erinacines A, B and C, strong stmulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum

, Tetrahedron Lett Int Organ Rapid Publ Prelim Commun Org Chem [Internet, 1994.

D. Sur,

K. Mori, S. Inatomi, K. Ouchi, Y. Azumi, and T. Tuchida, Improving efects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitve impairment: a double-blind placebo-controlled clinical trial, Phytother Res PTR. mars, vol.23, issue.3, pp.367-72, 2009.

K. Mori, Y. Obara, T. Moriya, S. Inatomi, and N. Nakahata, Efects of Hericium erinaceus on amyloid ?(25-35) peptde-induced learning and memory defcits in mice, Biomed Res Tokyo Jpn. févr, vol.32, issue.1, pp.67-72, 2011.

M. Nagano, K. Shimizu, R. Kondo, C. Hayashi, D. Sato et al., Reducton of depression and anxiety by 4 weeks Hericium erinaceus intake, Biomed Res Tokyo Jpn. août, vol.31, issue.4, pp.231-238, 2010.

M. Wang, N. Kanako, Y. Zhang, X. X. Gao, and K. Tetsuya, A unique polysaccharide purifed from Hericium erinaceus mycelium prevents oxidatve stress induced by H2O2 in human gastric mucosa epithelium cell, PloS One, vol.12, issue.7, p.181546, 2017.

H. Wang, Y. Cai, Y. Zheng, . Bai, D. Xie et al., Efcacy of biological response modifer lentnan with chemotherapy for advanced cancer: a meta-analysis, Cancer Med, vol.6, issue.10, pp.2222-2255, 2017.

K. Oba, M. Kobayashi, T. Matsui, Y. Kodera, and J. Sakamoto, Individual patent based meta-analysis of lentnan for unresectable/recurrent gastric cancer, Anticancer Res. juill, vol.29, issue.7, pp.2739-2784, 2009.

D. Zhang, J. Zheng, M. Ni, J. Wu, K. Wang et al., Comparatve efcacy and safety of Chinese herbal injectons combined with the FOLFOX regimen for treatng gastric cancer in China: a network metaanalysis, Oncotarget. 15 sept, vol.8, issue.40, pp.68873-89, 2017.

C. Signoreto, G. Burlacchini, A. Marchi, M. Grillenzoni, G. Cavalleri et al., Testng a low molecular mass fracton of a mushroom (Lentnus edodes) extract formulated as an oral rinse in a cohort of volunteers, J Biomed Biotechnol, vol.201, issue.1, p.857987, 2011.

J. Gaullier, J. Sleboda, E. S. Øford, E. Ulvestad, M. Nurminiemi et al., Supplementaton with a soluble ?-glucan exported from Shiitake medicinal mushroom, Lentnus edodes (Berk.) singer mycelium: a crossover, placebo-controlled study in healthy elderly, Int J Med Mushrooms, vol.13, issue.4, pp.319-345, 2011.

P. Lingström, E. Zaura, H. Hassan, M. J. Buijs, P. Hedelin et al., The Antcaries Efect of a Food Extract (Shiitake) in a Short-Term Clinical Study

. Biomed-research-international, , 2012.

J. Choi, D. Paik, D. Y. Kwon, and Y. Park, Dietary supplementaton with rice bran fermented with Lentnus edodes increases interferon-? actvity without causing adverse efects: a randomized, double-blind, placebo-controlled, parallel-group study, Nutr J. 22 avr, vol.13, p.35, 2014.

X. Dai, J. M. Stanilka, C. A. Rowe, E. A. Esteves, C. Nieves et al., Consuming Lentnula edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Interventon in Healthy Young Adults, J Am Coll Nutr, vol.34, issue.6, pp.478-87, 2015.

M. A. Id, P. Poucheret, S. Morel, M. Vitou, and L. Traoré, Lentinula edodes (Shiitake) et cancer : Propriétés pharmacologiques, Essais cliniques et Preuves d'efcacité. ICEPS conference, 2018.

, Levure de riz rouge et cholestérol

, Fleurance Nature, 2011.

D. Peng, A. Fong, A. Pelt, and . Van, Original Research: The Efects of Red Yeast Rice Supplementaton on Cholesterol Levels in Adults, Am J Nurs. août, vol.117, issue.8, pp.46-54, 2017.

M. Pirro, M. R. Mannarino, V. Bianconi, L. E. Simental-mendía, F. Bagaglia et al., The efects of a nutraceutcal combinaton on plasma lipids and glucose: A systematc review and meta-analysis of randomized controlled trials, Pharmacol Res, vol.110, pp.76-88, 2016.

J. Millán, A. Cicero, F. Torres, and A. Anguera, Efects of a nutraceutcal combinaton containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profle in hypercholesterolemic patents: A metaanalysis of randomised controlled trials, Clin E Investig En Arterioscler Publicacion Of Soc Espanola Arterioscler. août, vol.28, issue.4, pp.178-87, 2016.

M. C. Gerards, R. J. Terlou, H. Yu, C. Koks, and V. Gerdes, Traditonal Chinese lipid-lowering agent red yeast rice results in signifcant LDL reducton but safety is uncertain -a systematc review and metaanalysis, Atherosclerosis. juin, vol.240, issue.2, pp.415-438, 2015.

Y. Li, L. Jiang, Z. Jia, W. Xin, and Y. S. Yang, A meta-analysis of red yeast rice: an efectve and relatvely safe alternatve approach for dyslipidemia, PloS One, vol.9, issue.6, pp.98-611, 2014.

Y. C. Ong and Z. Aziz, Systematc review of red yeast rice compared with simvastatn in dyslipidaemia, J Clin Pharm Ther. avr, vol.41, issue.2, pp.170-179, 2016.

J. Huang, J. Frohlich, and A. P. Ignaszewski, The impact of dietary changes and dietary supplements on lipid profle, Can J Cardiol. août, vol.27, issue.4, pp.488-505, 2011.

H. T. Ong and J. S. Cheah, Statn alternatves or just placebo: an objectve review of omega-3, red yeast rice and garlic in cardiovascular therapeutcs, Chin Med J (Engl). 20 août, vol.121, issue.16, pp.1588-94, 2008.

L. K. Nies, A. A. Cymbala, S. L. Kasten, D. G. Lamprecht, and K. L. Olson, Complementary and alternatve therapies for the management of dyslipidemia, Ann Pharmacother, vol.40, issue.11, pp.1984-92, 2006.

X. Xiong, P. Wang, X. Li, Y. Zhang, and S. Li, The efects of red yeast rice dietary supplement on blood pressure, lipid profle, and C-reactve protein in hypertension: A systematc review, Crit Rev Food Sci Nutr. 13 juin, vol.57, issue.9, pp.1831-51, 2017.

S. Hasani-ranjbar, N. Nayebi, L. Moradi, A. Mehri, B. Larijani et al., The efcacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematc review, Curr Pharm Des, vol.16, issue.26, pp.2935-2982, 2010.

C. Stefen, Red yeast rice: An unsafe food supplement?, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. mars, vol.60, issue.3, pp.292-298, 2017.

. Anses--agence-natonale-de-sécurité-sanitaire-de-l'alimentaton, Saisine n°2012-SA-0228. Avis de l'Anses relatif aux risques liés à la présence de « levure de riz rouge » dans les compléments alimentaires, 2014.

H. W. Zhang, Z. X. Lin, Y. S. Tung, T. H. Kwan, C. K. Mok et al., Cordyceps sinensis (a traditonal Chinese medicine) for treatng chronic kidney disease. Cochrane Database Syst Rev, Disponible sur

T. Hong, M. Zhang, and J. Fan, Cordyceps sinensis (a traditonal Chinese medicine) for kidney transplant recipients, Cochrane Database Syst Rev, issue.10, p.9698, 2015.

Y. J. Sun, D. Sun, R. H. Gong, X. G. Zhong, X. T. Liu et al., Relatonship between ncRNAs and gastric cancer: meta-analysis, Bratisl Lek Listy, vol.118, issue.9, pp.535-543, 2017.

B. Y. Ong and Z. Aziz, Efcacy of Cordyceps sinensis as an adjunctve treatment in kidney transplant patents: A systematc-review and meta-analysis, Complement Ther Med. févr, vol.30, pp.84-92, 2017.

Y. Luo, S. Yang, X. Zhou, M. Wang, D. Tang et al., Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis) combined with angiotensin-convertng enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) versus ACEI/ARB alone in the treatment of diabetc kidney disease: a meta-analysis, Ren Fail. mai, vol.37, issue.4, pp.614-648, 2015.

H. Lo, C. Hsieh, F. Lin, and T. Hsu, A Systematc Review of the Mysterious Caterpillar Fungus Ophiocordyceps sinensis in Dong-ChongXiaCao ( D?ng Chóng Xià C?o) and Related Bioactve Ingredients, J Tradit Complement Med. janv, vol.3, issue.1, pp.16-32, 2013.

Z. D. Bao, Z. G. Wu, and F. Zheng,

F. Xu, J. B. Huang, L. Jiang, J. Xu, and J. Mi, Amelioraton of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney-transplanted recipients, Nephrol Dial Transplant Of Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.10, issue.1, pp.142-145, 1995.

L. Lu,

, Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi Chin J Integr Tradit West Med. mars, vol.22, issue.3, pp.169-71, 2002.

A. C. Parcell, J. M. Smith, S. S. Schulthies, J. W. Myrer, and G. Fellingham, Cordyceps Sinensis (CordyMax Cs-4) supplementaton does not improve endurance exercise performance, Int J Sport Nutr Exerc Metab. avr, vol.14, issue.2, pp.236-278, 2004.

M. Sun, Y. Yang, Y. Lu, R. Gao, L. Wang et al.,

, Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi Chin J Integr Tradit West Med. sept, vol.24, issue.9, pp.808-818, 2004.

S. N. Colson, F. B. Wyat, D. L. Johnston, L. D. Autrey, Y. L. Fitzgerald et al., Cordyceps sinensis-and Rhodiola rosea-based supplementaton in male cyclists and its efect on muscle tssue oxygen saturaton, J Strength Cond Res. mai, vol.19, issue.2, pp.358-63, 2005.

N. Wang, L. Jiang, X. Zhang, and Z. Li,

, Zhongguo Zhong Yao Za Zhi Zhongguo Zhongyao Zazhi China J Chin Mater Medica. août, vol.32, issue.15, pp.1566-1574, 2007.

Z. Zhang, W. Zhang, and K. Yao,

, Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi Chin J Integr Tradit West Med. sept, vol.28, issue.9, pp.806-815, 2008.

E. Wong, R. Sung, T. F. Leung, Y. O. Wong, A. Li et al., Randomized, double-blind, placebo-controlled trial of herbal therapy for children with asthma, J Altern Complement Med N Y N, vol.15, issue.10, pp.1091-1098, 2009.

S. Chen, Z. Li, R. Krochmal, M. Abrazado, W. Kim et al., Efect of Cs-4 (R) (Cordyceps sinensis) on Exercise Performance in Healthy Older Subjects: A Double-Blind, Placebo-Controlled Trial, J Altern Complement Med N Y N. 1 mai, vol.16, pp.585-90, 2010.

W. Yan, Y. Lei, W. Wu, Z. Zhang, Y. Liu et al., Preventon of disuse osteoporosis in rats by Cordyceps sinensis extract, Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. sept, vol.23, issue.9, pp.2347-57, 2012.

X. Wang, Y. Jiang, and C. Zhao,

, Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi Chin J Integr Tradit West Med. mars, vol.32, issue.3, pp.325-333, 2012.

K. Zhao, Y. Li, and H. Zhang, Role of dongchongxiacao (Cordyceps) in preventon of contrast-induced nephropathy in patents with stable angina pectoris, J Tradit Chin Med Chung Tsa Chih Ying Wen Pan. juin, vol.33, issue.3, pp.283-289, 2013.

Z. Kai, L. Yongjian, G. Sheng, and L. Yu, Efect of Dongchongxiacao (Cordyceps) therapy on contrast-induced nephropathy in patents with type 2 diabetes and renal insufciency undergoing coronary angiography, J Tradit Chin Med Chung Tsa Chih Ying Wen Pan. août, vol.35, issue.4, pp.422-429, 2015.

N. L. Klupp, H. Kiat, A. Bensoussan, G. Z. Steiner, and D. H. Chang, A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome, Sci Rep, vol.6, pp.29-540, 2016.

S. Tsuk, Y. H. Lev, A. Rotstein, R. Carasso, A. Zeev et al., Clinical Efects of a Commercial Supplement of Ophiocordyceps sinensis and Ganoderma lucidum on Cognitve Functon of Healthy Young Volunteers, Int J Med Mushrooms, vol.19, issue.8, pp.667-73, 2017.

Y. Li, W. Xue, P. Tian, X. Ding, H. Yan et al., Clinical applicaton of Cordyceps sinensis on immunosuppressive therapy in renal transplantaton, Transplant Proc. juin, vol.41, issue.5, pp.1565-1574, 2009.

M. Van-panhuys-sigler, Une ressource médicale himalayenne extraordinaire, Insecte, vol.4, issue.171, pp.13-20, 2013.

A. K. Panda and K. C. Swain, Traditonal uses and medicinal potental of Cordyceps sinensis of Sikkim, J Ayurveda Integr Med, vol.2, issue.1, pp.9-13, 2011.

M. Jesenak, S. Urbancek, J. Majtan, P. Banovcin, and J. Hercogova, ?-Glucan-based cream (containing pleuran isolated from pleurotus ostreatus) in supportve treatment of mild-to-moderate atopic dermatts, J Dermatol Treat. août, vol.27, issue.4, pp.351-355, 2016.

M. Jesenak, M. Hrubisko, J. Majtan, Z. Rennerova, and P. Banovcin, Ant-allergic efect of Pleuran (?-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infectons, Phytother Res PTR. mars, vol.28, issue.3, pp.471-475, 2014.

W. Jayasuriya, C. A. Wanigatunge, G. H. Fernando, D. Abeytunga, and T. S. Suresh, Hypoglycaemic actvity of culinary Pleurotus ostreatus and P. cystdiosus mushrooms in healthy volunteers and type 2 diabetc patents on diet control and the possible mechanisms of acton, Phytother Res PTR. févr, vol.29, issue.2, pp.303-312, 2015.

M. Jesenak, J. Majtan, Z. Rennerova, J. Kyselovic, P. Banovcin et al., Immunomodulatory efect of pleuran (?-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infectons, Int Immunopharmacol. févr, vol.15, issue.2, pp.395-404, 2013.

K. Bergendiova, E. Tibenska, and J. Majtan, Pleuran (?-glucan from Pleurotus ostreatus) supplementaton, cellular immune response and respiratory tract infectons in athletes, Eur J Appl Physiol. sept, vol.111, issue.9, pp.2033-2073, 2011.

M. Bobov?ák, R. Kuniaková, J. Gabri?, and J. Majtán, Efect of Pleuran (?-glucan from Pleurotus ostreatus) supplementaton on cellular immune response afer intensive exercise in elite athletes, Appl Physiol Nutr Metab Physiol Appl Nutr Metab. déc, vol.35, issue.6, pp.755-62, 2010.

J. De-oliveira-filho, M. T. Islam, E. S. Ali, S. J. Uddin, O. Santos-jv-de et al., A comprehensive review on biological propertes of citrinin, Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. déc, vol.110, pp.130-171, 2017.

S. Morel, F. Fons, G. Ninot, and S. Rapior, Les compléments alimentaires à base de champignons, 2013.

L. V. Mcfarland, Meta-analysis of probiotcs for the preventon of antbiotc associated diarrhea and the treatment of Clostridium difcile disease, Am J Gastroenterol. avr, vol.101, issue.4, pp.812-834, 2006.

H. Szajewska, A. Horvath, and M. Ko?odziej, Systematc review with meta-analysis: Saccharomyces boulardii supplementaton and eradicaton of Helicobacter pylori infecton, Aliment Pharmacol Ther. juin, vol.41, issue.12, pp.1237-1282, 2015.

S. Feizizadeh, A. Salehi-abargouei, and V. Akbari, Efcacy and safety of Saccharomyces boulardii for acute diarrhea, Pediatrics. juill, vol.134, issue.1, pp.176-191, 2014.

L. V. Mcfarland, Systematc review and meta-analysis of Saccharomyces boulardii in adult patents, World J Gastroenterol. 14 mai, vol.16, issue.18, pp.2202-2224, 2010.

H. Szajewska, A. Skórka, and M. Dylag, Meta-analysis: Saccharomyces boulardii for treatng acute diarrhoea in children, Aliment Pharmacol Ther. 1 févr, vol.25, issue.3, pp.257-64, 2007.

V. E. Rolfe, P. J. Fortun, and C. J. Hawkey, Bath-Hextall F. Probiotcs for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev, p.4826, 2006.

B. C. Johnston, A. L. Supina, and S. Vohra, Probiotcs for pediatric antbiotc-associated diarrhea: a metaanalysis of randomized placebo-controlled trials, CMAJ Can Med Assoc J J Assoc Medicale Can. 15 août, vol.175, issue.4, pp.377-83, 2006.

A. L. D'souza, C. Rajkumar, J. Cooke, and C. J. Bulpit, Probiotcs in preventon of antbiotc associated diarrhoea: meta-analysis, BMJ. 8 juin, vol.324, issue.7350, p.1361, 2002.

A. Cayzeele-decherf, F. Pélerin, S. Leuillet, B. Douillard, B. Housez et al., Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis, World J Gastroenterol. 14 janv, vol.23, issue.2, pp.336-380, 2017.

J. Z. Goldenberg, L. Lytvyn, J. Steurich, P. Parkin, S. Mahant et al., Probiotcs for the preventon of pediatric antbiotc-associated diarrhea. Cochrane Database Syst Rev, Disponible sur, 2015.

H. Chang, J. Chen, C. Lin, H. Lin, C. Peng et al., Multple strains probiotcs appear to be the most efectve probiotcs in the preventon of necrotzing enterocolits and mortality: An updated metaanalysis, PloS One, vol.12, issue.2, p.171579, 2017.

S. C. Ng, H. W. Hirai, K. Tsoi, S. H. Wong, F. Chan et al., Systematc review with meta-analysis: accuracy of interferon-gamma releasing assay and ant-Saccharomyces cerevisiae antbody in diferentatng intestnal tuberculosis from Crohn's disease in Asians, J Gastroenterol Hepatol. sept, vol.29, issue.9, pp.1664-70, 2014.

M. Ganji-arjenaki and M. Rafeian-kopaei, Probiotcs are a good choice in remission of infammatory bowel diseases: A meta analysis and systematc review, J Cell Physiol. mars, vol.233, issue.3, pp.2091-103, 2018.

H. Szajewska, R. B. Canani, A. Guarino, I. Hojsak, F. Indrio et al., Probiotcs for the Preventon of Antbiotc-Associated Diarrhea in Children, J Pediatr Gastroenterol Nutr. mars, vol.62, issue.3, pp.495-506, 2016.

, Commission european. Nutrition and Health Claims -European Commission

D. Sur,

, Propriétés et bienfaits de la levure de bière (focus cheveux et peau)

M. C. ,

K. Oba, S. Teramukai, M. Kobayashi, T. Matsui, Y. Kodera et al., Efcacy of adjuvant immunochemotherapy with polysaccharide K for patents with curatve resectons of gastric cancer, Cancer Immunol Immunother CII. juin, vol.56, issue.6, pp.905-916, 2007.

W. Eliza, C. K. Fai, and L. P. Chung, Efcacy of Yun Zhi (Coriolus versicolor) on survival in cancer patents: systematc review and meta-analysis. Recent Pat Infamm Allergy Drug Discov, janv, vol.6, issue.1, pp.78-87, 2012.

H. Fritz, D. A. Kennedy, M. Ishii, D. Fergusson, R. Fernandes et al., Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematc review, Integr Cancer Ther. mai, vol.14, issue.3, pp.201-212, 2015.

Y. Ma, X. Wu, J. Yu, J. Zhu, X. Pen et al., Can polysaccharide K improve therapeutc efcacy and safety in gastrointestnal cancer? a systematc review and network meta-analysis, Oncotarget, vol.8, issue.51, pp.89108-89126, 2017.

W. Y. Chay, C. K. Tham, H. C. Toh, H. Y. Lim, C. K. Tan et al., Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patents with Poor Liver Functon or Who Are Unft for Standard Therapy, J Altern Complement Med N Y N. août, vol.23, issue.8, pp.648-52, 2017.

A. Guesquiere, Se soigner grâce au mycelium des champignons, Internet]. FemininBio

D. Sur,

S. Morel, F. Fons, P. Poucheret, and S. Rapior, Les compléments alimentaires à base de champignons : bénéfices ou risques, 2013.

S. Garcia, TITRE Mycothérapie, de son usage traditonnel à ses perspectves d'utlisaton en pharmacie tttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt Résumé Le mot « mycothérapie », ou « traitement par les champignons » remonte probablement à 1997 lorsque le mycologue allemand Jan Ivan Lelley décrit, pour la première fois, la mycothérapie comme « la science de l'utlisaton des champignons aux vertus médicinales, Propriétés thérapeutques des champignons comestbles, vol.52, pp.11-16, 2009.

, Depuis la nuit des temps, les macromycètes occupent une place partculière dans le monde du vivant. Ils sont utlisés dans la Médecine Traditonnelle Chinoise (MTC) pour leurs nombreuses vertus

, Grifola frondosa, Hericium erinaceus, Lentinula edodes, Monascus purpureus, Ophiocordyceps sinensis, Pleurotus ostreatus et Saccharomyces cerevisiae, peut apporter un bénéfce pour soigner de nombreuses maladies telles que le cancer, le diabète, le cholestérol, la fatgue, les maladies rénale et hépatque, les troubles de la mémoire, La consommaton de champignons comme Agaricus subrufescens, Trametes versicolor, Ganoderma lucidum

, Le socle commun des champignons utlisés en thérapeutques est l'immunostmulaton : chacun d'entre eux possède une propriété de stmulaton du système immunitaire par sa compositon en ?-glucanes

, L'utlisaton de la mycothérapie doit s'intégrer dans une vision plus large de la prise en charge du patent. Notamment pour des pathologies délaissées par la médecine conventonnelle

, A l'heure actuelle, la mycothérapie n'est pas connue du grand public, le rôle de conseils du pharmacien d'ofcine sera donc déterminant afn d'en faire la promoton

M. Mycothérapie and . Traditonnelle-chinoise, Agaricus subrufescens, Trametes versicolor, Ganoderma lucidum, Grifola frondosa, Hericium erinaceus